MXCT

$1.46+0.69%visit website

MAXCYTE, INC.

Market Cap

$151M

Live price × SEC shares (Aug 7, 2026)

Sector

Health Care

Industry

Life Sciences Tools & Services

Beta (raw)

1.46

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

4.9

TTM to Jun 2026 · revenue

P/B

0.9

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	6,829	7,300	9,651	7,271	31,051
Cost of revenue	1,596	1,610	1,569	1,675	6,450
Gross profit	5,233	5,690	8,082	5,596	24,601
Research & development	5,316	3,335	3,857	4,253	16,761
Total operating expenses	19,382	16,916	14,267	15,828	66,393
Operating income	(14,149)	(11,226)	(6,185)	(10,232)	(41,792)
Pretax income	(12,416)	(9,596)	(4,750)	(8,874)	(35,636)
Net income	(12,416)	(9,596)	(4,750)	(8,874)	(35,636)
EPS (basic) ($)	(0.12)		(0.04)	(0.08)	(0.34)
EPS (diluted) ($)	(0.12)		(0.04)	(0.08)	(0.34)
Weighted avg. shares (basic)	106,613		106,875	106,823
Weighted avg. shares (diluted)	106,613		106,875	106,823

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 13, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 21 more quarters, back to Jun 2020, with Tormere Pro.

Corporate Events (8-K)

11 filings in 12 months · 2 with priority itemsFull history →

Filed	Items	Filing
Oct 14, 2026 accepted 8:10 AM ET	2.02Earnings release	Document SEC ↗
Aug 12, 2026 accepted 4:14 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Jun 17, 2026 accepted 4:59 PM ET	5.07Shareholder vote	Document SEC ↗
Jun 16, 2026 accepted 4:21 PM ET	3.01Delisting notice	Document SEC ↗
May 12, 2026 accepted 4:12 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Mar 27, 2026 accepted 4:54 PM ET	5.02Officer / director change	Document SEC ↗
Mar 24, 2026 accepted 4:15 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Mar 20, 2026 accepted 4:40 PM ET	3.01Delisting notice	Document SEC ↗
Jan 12, 2026 accepted 4:45 PM ET	2.02Earnings release	Document SEC ↗
Nov 12, 2025 accepted 4:13 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗